276 related articles for article (PubMed ID: 8765625)
21. Prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D-dimers in acute deep vein thrombosis: effects of heparin treatment.
Estivals M; Pelzer H; Sie P; Pichon J; Boccalon H; Boneu B
Br J Haematol; 1991 Jul; 78(3):421-4. PubMed ID: 1873225
[TBL] [Abstract][Full Text] [Related]
22. Influence of heparin treatment on biochemical markers of an activation of the coagulation system.
Amelsberg A; Zurborn KH; Gärtner U; Kiehne KH; Preusse AK; Bruhn HD
Thromb Res; 1992 May; 66(2-3):121-31. PubMed ID: 1412188
[TBL] [Abstract][Full Text] [Related]
23. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of an extracorporeal membrane oxygenation system using a nonporous membrane oxygenator and a new method for heparin coating.
Kitano Y; Takata M; Miyasaka K; Sasaki N; Zhang Q; Liu D; Tsuchida Y
J Pediatr Surg; 1997 May; 32(5):691-7. PubMed ID: 9165453
[TBL] [Abstract][Full Text] [Related]
25. Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation.
Stansfield BK; Wise L; Ham PB; Patel P; Parman M; Jin C; Mathur S; Harshfield G; Bhatia J
J Pediatr Surg; 2017 Apr; 52(4):609-613. PubMed ID: 27847121
[TBL] [Abstract][Full Text] [Related]
26. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.
Slaughter TF; LeBleu TH; Douglas JM; Leslie JB; Parker JK; Greenberg CS
Anesthesiology; 1994 Mar; 80(3):520-6. PubMed ID: 8141448
[TBL] [Abstract][Full Text] [Related]
27. Effects of warfarin on markers of hypercoagulability in patients with heart failure.
Jafri SM; Mammen EF; Masura J; Goldstein S
Am Heart J; 1997 Jul; 134(1):27-36. PubMed ID: 9266780
[TBL] [Abstract][Full Text] [Related]
28. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
Bremme K; Lind H; Blombäck M
Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
[TBL] [Abstract][Full Text] [Related]
29. Comparison of markers of coagulation activation in patients under oral anticoagulation at different levels.
van Wersch JW; van Mourik-Alderliesten CH; Coremans A
Eur J Clin Chem Clin Biochem; 1992 Aug; 30(8):461-6. PubMed ID: 1445959
[TBL] [Abstract][Full Text] [Related]
30. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a new heparin bonding process in prolonged extracorporeal membrane oxygenation.
Nojiri C; Hagiwara K; Yokoyama K; Kurbayashi E; Hidaka K; Ishida N; Horiuchi K; Oshiyama H; Nogawa A; Kido T
ASAIO J; 1995; 41(3):M561-7. PubMed ID: 8573868
[TBL] [Abstract][Full Text] [Related]
32. Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation.
Nankervis CA; Preston TJ; Dysart KC; Wilkinson WD; Chicoine LG; Welty SE; Nelin LD
ASAIO J; 2007; 53(1):111-4. PubMed ID: 17237658
[TBL] [Abstract][Full Text] [Related]
33. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW
J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458
[TBL] [Abstract][Full Text] [Related]
34. [Changes in antithrombin III, prothrombin fragment 1 + 2 and thrombin-antithrombin III complex following implantation of a coronary Palmaz-Schatz stent].
Dittel M; Haushofer A; Spiel R; Halbmayer WM; Prachar H; Fischer M; Mlczoch J
Z Kardiol; 1995 Jan; 84(1):22-9. PubMed ID: 7863710
[TBL] [Abstract][Full Text] [Related]
35. Markers of in vivo activation of coagulation. Interrelationships change with intensity of oral anticoagulation.
Solymoss S; Bovill EG
Am J Clin Pathol; 1996 Mar; 105(3):293-7. PubMed ID: 8602609
[TBL] [Abstract][Full Text] [Related]
36. Markers of coagulation activation for evaluation of the antithrombotic efficacy of heparin: a prospective study in acute deep venous thrombosis.
Mesters RM; Mikoteit T; Schiller M; Krings W; Ostermann H; Kienast J
Blood Coagul Fibrinolysis; 1995 Oct; 6(7):665-71. PubMed ID: 8562838
[TBL] [Abstract][Full Text] [Related]
37. Hemolysis during long-term extracorporeal membrane oxygenation.
Steinhorn RH; Isham-Schopf B; Smith C; Green TP
J Pediatr; 1989 Oct; 115(4):625-30. PubMed ID: 2795361
[TBL] [Abstract][Full Text] [Related]
38. Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the caerphilly study.
Lowe GD; Rumley A; Sweetnam PM; Yarnell JW; Rumley J
Thromb Haemost; 2001 Sep; 86(3):822-7. PubMed ID: 11583314
[TBL] [Abstract][Full Text] [Related]
39. Maintaining adequate anticoagulation on extracorporeal membrane oxygenation therapy: Hemochron Junior Low Range versus Hemochron 400.
Colby CE; Sheehan A; Benitz W; Van Meurs K; Halamek LP; Moss RL
J Extra Corpor Technol; 2003 Mar; 35(1):35-8. PubMed ID: 12680494
[TBL] [Abstract][Full Text] [Related]
40. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation.
Ranucci M; Ballotta A; Kandil H; Isgrò G; Carlucci C; Baryshnikova E; Pistuddi V;
Crit Care; 2011; 15(6):R275. PubMed ID: 22099212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
